Declining Pulmonary Function in Interstitial Lung Disease Linked to Lymphocyte Dysfunction.
Pubmed ID: 31661301
Pubmed Central ID: PMC7047459
Journal: American journal of respiratory and critical care medicine
Publication Date: March 1, 2020
MeSH Terms: Humans, Disease Progression, Vital Capacity, Sarcoidosis, Pulmonary, Lymphocytes, Gene Expression, Pulmonary Diffusing Capacity, Idiopathic Pulmonary Fibrosis, CD40 Ligand, GATA3 Transcription Factor, Ikaros Transcription Factor, Inducible T-Cell Co-Stimulator Protein, Nuclear Receptor Subfamily 1, Group F, Member 1, Receptors, CCR4, Receptors, CCR6, Receptors, CCR7, T-Box Domain Proteins
Grants: F30 HL137267, R01 HL138628
Authors: Ascoli C, Huang Y, Perkins DL, Finn PW, Schott CA
Cite As: Schott CA, Ascoli C, Huang Y, Perkins DL, Finn PW. Declining Pulmonary Function in Interstitial Lung Disease Linked to Lymphocyte Dysfunction. Am J Respir Crit Care Med 2020 Mar 1;201(5):610-613.
Studies: